|
|
Volumn 66, Issue 3, 2001, Pages 210-212
|
|
Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-β
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PLATELET DERIVED GROWTH FACTOR;
PREDNISOLONE;
TRANSFORMING GROWTH FACTOR BETA;
VINCRISTINE;
ADULT;
CASE REPORT;
CYTOTOXIC T LYMPHOCYTE;
FEMALE;
HUMAN;
LETTER;
LYMPHADENOPATHY;
MYELOFIBROSIS;
PANCYTOPENIA;
PRIORITY JOURNAL;
T CELL LYMPHOMA;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOPHENOTYPING;
LYMPHOMA, T-CELL, PERIPHERAL;
MYELOFIBROSIS;
NEOPLASM PROTEINS;
PANCYTOPENIA;
PLATELET-DERIVED GROWTH FACTOR;
PREDNISOLONE;
REMISSION INDUCTION;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSFORMING GROWTH FACTOR BETA;
TRANSPLANTATION, HOMOLOGOUS;
TUMOR MARKERS, BIOLOGICAL;
VINCRISTINE;
|
|
EID: 0035055026
PISSN: 09024441
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0609.2001.00302.x Document Type: Letter |
|
Times cited : (18)
|
|
References (8)
|
